GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (WBO:ABBV) » Definitions » Inventories, Finished Goods

AbbVie (WBO:ABBV) Inventories, Finished Goods : €1,214 Mil (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is AbbVie Inventories, Finished Goods?

AbbVie's quarterly finished goods declined from Mar. 2024 (€1,157 Mil) to Jun. 2024 (€1,105 Mil) but then increased from Jun. 2024 (€1,105 Mil) to Sep. 2024 (€1,214 Mil).

AbbVie's annual finished goods increased from Dec. 2021 (€825 Mil) to Dec. 2022 (€1,097 Mil) and increased from Dec. 2022 (€1,097 Mil) to Dec. 2023 (€1,243 Mil).


AbbVie Inventories, Finished Goods Historical Data

The historical data trend for AbbVie's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbbVie Inventories, Finished Goods Chart

AbbVie Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 436.50 1,083.40 824.82 1,096.93 1,243.45

AbbVie Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 969.80 1,243.45 1,157.36 1,104.58 1,213.65

AbbVie Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.


AbbVie Business Description

Industry
Address
1 North Waukegan Road, North Chicago, IL, USA, 60064-6400
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).